3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Underutilization of partial nephrectomy for localized renal cell carcinoma in the U.S.

CancerMar 31, 06

In the past, the gold standard for the treatment of localized renal tumors has been radical nephrectomy. Over time however, experience with nephron sparing surgery and, now, laparoscopic approaches have demonstrated oncologic equipoise and may provide for an improved quality of life for patients as compared to those undergoing radical nephrectomy for localized renal masses.

The incidence of localized small renal tumors is increasing (3.8-5.6% annually) and one would predict that the incidence of nephron sparing approaches would increase in concert. Though more technically demanding than radical nephrectomy, nephron sparing offers the intuitive benefit of maximizing residual functioning renal tissue, while maintaining cancer control. A recent evaluation of the SEER database revealed that in 2001, 58% of patients with tumors < 2cm, and 80% of patients with tumors 2-4 cm were managed with radical nephrectomy. This study by Hollenbeck and colleagues suggests that while the use of nephron sparing approaches in the management of small renal masses has increased, it remains underutilized and very much regionalized to urban, teaching, high volume centers in the United States.

The authors used the Nationwide Inpatient Sample database to identify patients undergoing partial or radical nephrectomy in the United States during the period 1988-2002. The authors identified 66,621 patients who underwent either partial or radical nephrectomy during the study period, 7.5% of whom underwent partial nephrectomy. The authors noted that the frequency of partial nephrectomy increased during the study period from 3.7% in 1988 to 12.3% in 2002 (p< 0.001). Moreover the utilization rates for partial nephrectomy increased during the study period from 0.21/100,000 population in 1988 to 1.6/100,000 population in 2002 (p< 0.001). However, the authors noted that the utilization rates of radical nephrectomy also increased during the study period from 7.3/100,000 population in 1988 to 9.8/100,000 population in 2002 (p< 0.0001). Examining odds ratios (OR), patients were more likely to undergo partial nephrectomy at urban (OR 1.1), teaching (OR 1.3), high nephrectomy volume (defined as ??28 nephrectomies/year) (OR 2.5) centers. Utilization of partial nephrectomy at such centers ranged from 33-52%.

This study further demonstrates the regionalization of specialized, technically demanding surgical procedures such as partial nephrectomy to major tertiary care teaching centers. It is alarming that despite the acceptance of partial nephrectomy as an oncologically viable procedure in anatomically receptive tumors, more than half of all tumors < 2cm and 80% of tumors 2 ?C 4cm in diameter are still managed with radical nephrectomy. The contribution of laparoscopic radical nephrectomy as an alternative to open partial nephrectomy has yet to be quantified and may further the underutilization of nephron sparing approaches.

By Christopher G. Wood, MD



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site